60 Degrees Pharmaceuticals Awarded Canadian Patent Covering Tafenoquine For Prevention Of Malaria In Malaria-Naive Subjects
Portfolio Pulse from Benzinga Newsdesk
60 Degrees Pharmaceuticals has been awarded a Canadian patent for Tafenoquine, a drug used for the prevention of malaria in malaria-naive subjects.
July 31, 2023 | 12:01 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
60 Degrees Pharmaceuticals, potentially related to SXTP, has secured a Canadian patent for Tafenoquine, which could enhance its market position.
The award of a patent for Tafenoquine to 60 Degrees Pharmaceuticals, which may be related to SXTP, could strengthen its market position and potentially lead to increased revenues. This could have a positive impact on SXTP's stock price in the short term.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 50